You are using an older version of Internet Explorer that is not supported on this site. Please upgrade for the best experience.

Breast Cancer Trials

Click on a trial to find out the eligibility requirements and who to contact if you have questions about participating.

Page 1 of 1 | Results 1 - 9 of 9

A Metastatic breast cancer trial

Grace Makari-Judson, MD
Cancer - Breast, Cancer

D'Amour Center for Cancer Care
3350 Main Street
Springfield, MA 01199

A Phase III trial evalutaing use of adjuvant endorcrine therapy in patients with high-risk hormone receptor-positive and HER2/negative Breast Cancer

The purpose of this study is to see whether treatment with everolimus plus hormone treatment after chemotherapy will increase the time without your cancer returning.  The current standard treatment after chemotherapy is hormone treatment alone. The combination of hormone-treatment and everolimus is experimental in patients with breast cancer.
Grace Makari-Judson, MD
Cancer - Breast, Cancer

D’Amour Center for Cancer Care
3350 Main Street
Springfield, MA 01199

A Phase III trial to assess efficacy and safety of chemotherapy as an adjuvant treatment for patients with BRCA1/2 Mutations and high risk Her2 negative primary breast cancer

Grace Makari-Judson, MD
Cancer, Cancer - Breast

D’Amour Center for Cancer Care
3350 Main Street
Springfield MA 01199

A Randomized Phase III Clinical Trial Evaluating Post-Mastectomy Chest Wall and Regional Nodal XRT and Post-Lumpectomy Regional Nodal XRT in Patients with Positive Axillary Nodes Before Neoadjuvant Chemotherapy Who Convert to Pathologically Negative Axillary Nodes After Neoadjuvant Chemotherapy

This study evaluates whether the addition of chestwall + regional nodal XRT after mastectomy or breast + regional nodal XRT after breast conserving surgery will significantly reduce the rate of events for invasive breast cancer recurrence-free interval (IBC-RFI) in patients who present with histologically positive axillary nodes but convert to histologically negative axillary nodes following neoadjuvant chemotherapy.

Seth Kaufman, MD
Cancer - Breast

D'Amour Center for Cancer Care 

A phase II trial to study rare tumors

John McCann, MD
Cancer, Cancer - Brain, Cancer - Breast, Cancer - Colon, Cancer - Esophogus, Cancer-Gynecologic, Cancer - Kidney, Cancer - Leukemia, Cancer - Lung, Cancer - Lymphoma, Cancer - Melanoma, Cancer - Multiple Myeloma, Cancer - Pancreatic, Cancer - Prostate

D'Amour Center for Cancer Care
3350 Main Street
Springfield, MA 01199

Baystate Franklin Medical Center
164 High Street
Greenfield, MA 01301

A randomized phase III trial evaluating the role of axillary lymph node dissection in breast cancer patients (ct1-3 n1) who have positive sentinel lymph node disease after neoadjuvant chemotherapy

Seth Kaufman, MD
Cancer - Breast

D’Amour Center for Cancer Care

Breast Cancer Survivor Trial

Grace Makari-Judson, MD
Cancer, Cancer - Breast

D'Amour Center for Cancer Care
3350 Main Street
Springfield, MA 01199

Creation of breast research registry

The purpose of this project is to create a research registry (a place to store large amounts of data) so we can use it for later studies regarding breast health and breast cancer.
Grace Makari-Judson, MD
Cancer - Breast, Cancer

Baystate Breast and Wellness Center
100 Wason Avenue, 3rd Floor
Springfield, MA

D’Amour Center for Cancer Care
3350 Main Street
Springfield, MA

Selected plastic surgery offices in Springfield

Molecular Analysis for Therapy Choice (MATCH)

John McCann, MD
Cancer, Cancer - Brain, Cancer - Breast, Cancer - Colon, Cancer - Esophogus, Cancer-Gynecologic, Cancer - Kidney, Cancer - Leukemia, Cancer - Lung, Cancer - Lymphoma, Cancer - Melanoma, Cancer - Multiple Myeloma, Cancer - Pancreatic, Cancer - Prostate

D'Amour Center for Cancer Care
3350 Main Street
Springfield, MA 01199

Page 1 of 1 | Results 1 - 9 of 9